← Back to Search

Parent Activation for Substance Use Disorders (LEAP Trial)

Waitlist Available
Led By Michael McCart, Ph.D.
Research Sponsored by Oregon Social Learning Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up baseline to 36 months
Awards & highlights

LEAP Trial Summary

This trial will test whether task-shifting juvenile probation/parole officers to deliver parent activation, an EBP, can increase treatment engagement and improve JJ youth outcomes in rural communities.

Who is the study for?
This trial is for juvenile probation/parole officers in certain counties of Idaho or Oregon. It's designed to help them learn how to activate parents, aiming to improve outcomes for youth with substance use and antisocial behavior issues.Check my eligibility
What is being tested?
The study is testing a new approach called 'parent activation' against the usual services provided by the juvenile justice system. The goal is to see if this method can better engage parents and support youth treatment in rural areas.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating.

LEAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes from Baseline scores compared to 36 months post-Baseline on fidelity to Parent Activation (measured at Baseline, End of Usual Services phase, every 3 months for 9 months, and then every 6 months until 36 months post-Baseline).
Changes in number and severity of criminal charges in de-identified youth records from Baseline compared with 36 months post-Baseline.
Secondary outcome measures
Changes from Baseline in attitudes towards Evidence-Based practices compared to 36 months post-Baseline (measured at 0, 6, 12, 18, 24, 30, and 36 months).
Changes from Baseline in de-identified family outcomes (parent attendance and the number of positive youth drug screens) compared to 36 months post-Baseline (measured biweekly for 36 months).
Changes from Baseline in perceived agency support of evidence-based practices implementation compared to 36 months post-Baseline (measured at 0, 6, 12, 18, 24, 30, and 36 months).
+4 more

LEAP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Parent ActivationExperimental Treatment1 Intervention
This group of JPOs will deliver Parent Activation as a service to the juveniles and families on their caseloads.
Group II: Usual ServicesActive Control1 Intervention
This group of JPOs will deliver services as usual to the juveniles and families on their caseloads.

Find a Location

Who is running the clinical trial?

Oregon Social Learning CenterLead Sponsor
35 Previous Clinical Trials
10,634 Total Patients Enrolled
3 Trials studying Substance Abuse
441 Patients Enrolled for Substance Abuse
Michael McCart, Ph.D.Principal InvestigatorOregon Social Learning Center

Media Library

Parent Activation Clinical Trial Eligibility Overview. Trial Name: NCT04779229 — N/A
Substance Abuse Research Study Groups: Parent Activation, Usual Services
Substance Abuse Clinical Trial 2023: Parent Activation Highlights & Side Effects. Trial Name: NCT04779229 — N/A
Parent Activation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04779229 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What ambitions is this experiment attempting to fulfill?

"This clinical trial, which will be conducted over a period of 36 months starting from Baseline, aims to measure changes in Parent Activation fidelity (measured at the beginning and subsequently every 3 months for 9 months then bi-annually until the conclusion). Furthermore secondary outcomes such as Maslach Burnout Inventory ratings, Parent Self-Agency Measure scores, and Evidence-Based Practice Attitude Scale results will also be recorded. These assessments are expected to take place during regular intervals throughout the duration of this study."

Answered by AI

Does this research encompass individuals aged 55 or over?

"The target patient population for this trial is comprised of individuals younger than 80 years and older than 18."

Answered by AI

Is this research currently enrolling participants?

"The trial report hosted on clinicaltrials.gov illustrates that this specific study is not actively seeking new participants, as it was last updated on January 16th 2022. Nonetheless, 362 other trials are currently recruiting individuals for medical studies."

Answered by AI

Do I meet the qualifications to participate in this experiment?

"This medical study is seeking between 103 and 18- to 80-year-olds with a history of substance misuse as participants."

Answered by AI
~7 spots leftby Jun 2024